ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40949486

Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases.

Sun M and 6 others. MedComm (2020), 2025. Cited by 18 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases. Papers, record 40949486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40949486

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exosome-Based Therapeutics: A Natural Solution to Overcoming the Blood-Brain Barrier in Neurodegenerative Diseases.
PubMed
Journal
MedComm (2020)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
5.56, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun MMin
2Qin FFeng
3Bu QQian
4Zhao YYue
5Yang XXiaofeng
6Zhang DDingwen
7Cen XXiaobo

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References409

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,664,060Extracellular vesicles derived from astrocyte-treated with haFGF14-154 attenuate Alzheimer phenotype in AD mice.Theranostics2022https://conductscience.org/library/papers/35664060PubMed
231,934,599Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice.Mol Ther Methods Clin Dev2020https://conductscience.org/library/papers/31934599PubMed
327,770,892Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.Mater Sci Eng C Mater Biol Appl2017https://conductscience.org/library/papers/27770892PubMed
429,699,940Hydrophobicity of Lipid-Conjugated siRNAs Predicts Productive Loading to Small Extracellular Vesicles.Mol Ther2018https://conductscience.org/library/papers/29699940PubMed
531,907,330[Current Clinical Trials in the Treatment of Alzheimer's Disease].Brain Nerve2020https://conductscience.org/library/papers/31907330PubMed
631,843,452Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy.Mol Ther2020https://conductscience.org/library/papers/31843452PubMed
732,814,093Cancer therapy based on extracellular vesicles as drug delivery vehicles.J Control Release2020https://conductscience.org/library/papers/32814093PubMed
834,680,100Extracellular Calcium Influx Pathways in Astrocyte Calcium Microdomain Physiology.Biomolecules2021https://conductscience.org/library/papers/34680100PubMed
940,347,374Exploring Exosome-Based Approaches for Early Diagnosis and Treatment of Neurodegenerative Diseases.Mol Neurobiol2025https://conductscience.org/library/papers/40347374PubMed
1039,806,451Emerging role of exosomes in cancer therapy: progress and challenges.Mol Cancer2025https://conductscience.org/library/papers/39806451PubMed

1 to 10 of 409

See all 409 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42,964,764Precision engineering of nanocarriers for transport across complex biological barriers.Int J Pharm X2026https://conductscience.org/library/papers/42964764PubMed
42,882,510Exosomes and Extracellular Vesicles in Oncology: Next-Generation Smart Nanocarriers for Precision Cancer Therapy.Cells2026https://conductscience.org/library/papers/42882510PubMed
42,877,578From scavenger to victim: mechanism and treatment of microglial ferroptosis in white matter injury disease.Front Immunol2026https://conductscience.org/library/papers/42877578PubMed
42,797,527Role of the Blood-Brain Barrier in the Pathophysiology of Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A Comparative Review.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42797527PubMed
42,742,907Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease.Inflammopharmacology2026https://conductscience.org/library/papers/42742907PubMed
42,742,878Epigenetic Insights and Exosome-Based Therapeutics for Insomnia: Bridging Sleep Biology and Precision Medicine.Mol Neurobiol2026https://conductscience.org/library/papers/42742878PubMed
42,668,536SRT1720-loaded exosome-mimetic nanovesicles promote mitophagy via SIRT1/PARKIN activation to ameliorate diabetic cerebral infarction in a preclinical rat model.Int J Pharm X2026https://conductscience.org/library/papers/42668536PubMed
42,662,413From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease.Mater Today Bio2026https://conductscience.org/library/papers/42662413PubMed
42,603,243Restoration of Neuronal Metabolism and Memory in Alzheimer's Disease by Reprogramming the Exosomal microRNA Network.J Mol Neurosci2026https://conductscience.org/library/papers/42603243PubMed
42,512,450Molecular Mechanisms of Neurodegenerative Diseases: Emerging Biomarkers and Therapeutic Targets.Brain Sci2026https://conductscience.org/library/papers/42512450PubMed

1 to 10 of 21

See all 21 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40949486

GET https://conductscience.org/api/papers/v1/40949486/references?page=2

API referenceFor AI assistants